RT Journal Article
SR Electronic
T1 Epidemiology of gout
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP S9
OP S12
VO 75
IS 7 suppl 5
A1 Mandell, Brian F.
A1 Weaver, Arthur L.
YR 2008
UL http://www.ccjm.org/content/75/7_suppl_5/S9.abstract
AB The incidence and prevalence of gout are rising, likely as a result of a changing pattern of risk factors. At-risk populations are growing, due to the fact that people are living longer. Longevity and current dietary and lifestyle choices have also contributed to increased rates of co-morbidities associated with hyperuricemia and gout. The use of medications to treat such comorbidities also plays a role in some cases of gout. While dietary and lifestyle modification may be useful as adjunctive measures, such changes do not replace pharmacologic treatments for gout or associated comorbidities.